You are on page 1of 2

“My doctor ordered Do you find yourself saying

“The treatments we have tried so far

PA N DA S
the Cunningham Panel ™ aren’t working?”

for my son and that gave Symptoms that might trigger a clinician
to consider PANDAS/PANS

PA N S
him a clearer picture that PHYSICAL (A sudden onset or departure from the norm of)

my child has PANDAS/ • Vocal/motor tics of any type, severity or duration


• Sensory or motor abnormalities

PANS. After receiving


• Sleep disturbances
• Enuresis/urinary issues
PA N DA S
treatment, we are finally
• Anorexia
PEDIATRIC AUTOIMMUNE NEUROPSYCHIATRIC
BEHAVIORAL (A sudden onset or departure from the norm of) MOLECULERA LABS, INC.
DISORDER ASSOCIATED WITH
seeing the son we • Anxiety or unusual fears, separation anxiety
• Emotional lability and/or depression
755 Research Parkway, Suite 410
Oklahoma City, Oklahoma 73104 STREPTOCOCCAL INFECTIONS

remember.” • Irritability, aggression, or rage


405.239.5250 405.239.5255
• Oppositional/defiant behaviors PHONE: FAX:
PA N S
• Behavioral (or developmental) regression
customerservice@moleculera.com PEDIATRIC ACUTE-ONSET
• Deterioration in school performance
M O L E C U L E R A .C O M NEUROPSYCHIATRIC SYNDROME
• Obsessions/Compulsions
• Inability to concentrate
• Impulsivity/Distraction
• Separation Anxiety
• Worrying about harm
• Changes in handwriting

In more chronic cases, clinicians may see


seemingly unrelated symptom clusters
in the patient who is not responding to B EC AU S E YO U N E E D
treatment as the clinician would expect. A N S W E R S & U N D E R S TA N D I N G
What is PANDAS/PANS? The CUNNINGHAM PANEL™ of Tests How to CREATE AN ACCOUNT How to ORDER THE CUNNINGHAM PANEL™

PANDAS/PANS is an infection triggered PANDAS/PANS is a clinical diagnosis made CREATING AN ACCOUNT ORDERING A PANEL
autoimmune condition that interferes with This process takes a clinician or office personnel 1. Go to moleculera.com
by a clinician. The Cunningham Panel™ is an
normal neurologic activity. In PANDAS/ approximately 5 minutes, or less, and only needs to be 2. Click on the tab labeled Physicians
aid to the clinician in making their diagnosis.
PANS patients, antibodies recognize and done once. 3. Scroll down to the bottom of the page and click
The Cunningham Panel™ can help identify
mistakenly attack normal receptors and 1. Go to moleculera.com on the button labeled Physician Portal
antigens found within the brain.
the level of antibodies and their capability to
2. Click on the tab labeled Physicians 4. Input your email address and password
stimulate and trigger neurological symptoms. 3. Scroll down to the bottom of the page and click on
This molecular mimicry based attack can 5. Read and accept the consent form
be directed against dopamine receptors, the button labeled Physician Portal
The Cunningham Panel™ consists of 5 assays. The first 4 6. Select Request New Test
lysoganglioside, tubulin, and other 4. Enter the following information to register:
assays yield results that are expressed as a titer or final 7. Follow the prompts to input patient information
Clinician’s First and Last Name, Degree, NPI Number
neurologic targets located within the dilution at which an endpoint reaction was observed on Clinic Name, Specialty, Address, Phone/Fax/Email
8. Click NEXT
brain. Binding can interfere with, or cause an Enzyme-Linked Immunosorbent Assay (ELISA) format.
over stimulation of neurologic activity. 5. You will receive a confirmation email with a Be sure to have and verify your patient’s or their
These assays measure circulating levels of autoantibodies
temporary password. Please click on the link in the guardian’s email address to input when prompted.
This can contribute to a whole host of directed against specific neuronal antigens in the patient email and change the password in order to complete
movement and neuropsychiatric disorders, This is how we reach the patient and request their
including: Dopamine D1 Receptor (DRD1), Dopamine D2L your registration.
OCD, and abnormal neurologic behavior. insurance and payment information.
Receptor (DRD2L), Lysoganglioside – GM1, and Tubulin.

Often, this condition may be treated only After the test requisition has been initiated by the
The fifth assay, CaM Kinase II Activation, yields a physician or physician’s representative, the Patient/
symptomatically with neuropsychiatric
laboratory value (expressed as a numeric score) that Parent/Guardian will receive an email with the Patient
drugs, but the underlying basis is an
reflects the percent of baseline CaM Kinase activity in a ID number and will be able to click on a link to input
infection triggered autoimmune disorder
attacking the brain. human neuronal cell line and is a part of the activation insurance/deposit information.
pathway for the production of dopamine. Identification
of these autoimmune antibodies directed against specific
neurologic receptors may assist the clinician in making an
accurate and timely diagnosis.

You might also like